You can buy or sell Kamada and other stocks, options, and ETFs commission-free!
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel. The listed name for KMDA is Kamada Ltd. Ordinary Shares.
52 Week High
52 Week Low
— per share
Expected Feb 11, Pre-Market